The exosome diagnostics and therapeutics market was estimated to be US$ 76.03 Mn in 2021 and US$ xx Bn in 2023. It is expected to reach US$ 1542.45 Mn by 2031 and record a CAGR of 35.1% until 2031. Continued advancements in exosome research and technology, improved isolation techniques, and exosome engineering to enhance therapeutic applications will likely remain key exosome diagnostics and therapeutic market trends.

Exosome Diagnostics and Therapeutics Market Analysis

The increasing prevalence of chronic diseases is expected to grow the exosome diagnostics and therapeutics market. Exosomes are involved in the pathogenesis of diseases, such as cancer, pregnancy disorders, neurodegenerative diseases, and cardiovascular diseases, and are potential non-invasive biomarkers for the diagnosis, prognosis, and therapeutics of a myriad of diseases. As per the European Commission, there were 2.74 million new cancer cases in the EU Member States.

Exosome Diagnostics and Therapeutics Market Overview

The global exosome diagnostics and therapeutics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The market growth in this region is expected due to factors such as increasing demand for novel diagnostic therapeutics, developing overall healthcare infrastructure, and increasing awareness regarding benefits offered by exosome-based diagnostics. However, lack of expertise is likely to restrain the market growth to a certain extent.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Exosome Diagnostics and Therapeutics Market: Strategic Insights

Exosome Diagnostics and Therapeutics Market

• 
  CAGR (2023 - 2031)

  35.1%
• Market Size 2021
  US$ 76.03 Million
• Market Size 2031
  US$ 1542.45 Million

Market Dynamics

GROWTH DRIVERS

• Rise in Exosome Research and Development Activities

FUTURE TRENDS

• Automation of Exosome Isolation Process

OPPORTUNITIES

• Growing Preference for Non-invasive and Novel Diagnostic Procedures

Key Players

• Aethlon Medical, Inc,
• Therapeutic Solutions International, Inc,
• ReNeuron Group plc,
• Immune Therapy Holdings AB,
• Cell Guidance Systems LLC,
• BioRegenerative Sciences,
• Evomic Science LLC,
• Norgen Biotek Corp,
• Exosome Diagnostics, Inc.
• Bio-Techne,

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Product

• Diagnostic
• Therapeutic

Service

• Instrument
• Reagents
• Software

End User

• Cancer Institutes
• Hospitals
• Diagnostic Centers
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Exosome Diagnostics and Therapeutics Market Drivers and Opportunities

Rise in Research and Development Activities is Likely to Favor The Market.

Several market players and healthcare organizations are implementing strategies to boost research and development activities on exosome applications. For instance, a research study on ‘Exosomes: Potential Disease Biomarkers and New Therapeutic Targets’ was conducted in the Department of Medicine, Universidad del Norte, Barranquilla, Colombia. The study presented perspectives on the use of exosomes in future clinical practice.

Owing to these factors, exosome diagnostics and therapeutic is gaining importance.

Growing Preference for Non-invasive and Novel Diagnostic Procedure– An Opportunity in Exosome Diagnostics and Therapeutics Market

Exosomes facilitate intercellular communications through the exchange of lipids and proteins between the exosome-producing cells and target cells. Moreover, they enable intracellular communication through the horizontal transfer of biomolecules between cells and their microenvironment. Ongoing research studies have demonstrated the imperative physiological roles of exosomes in the diagnosis of cardiovascular, immune, and neural diseases, as well as in the pathogenesis of chronic conditions such as cancer. A significant number of startups are coming into the market with an aim to fulfill the need of novel invasive diagnostic procedures. For instance, in 2015, a group of researchers launched a new company, Exocan, with the major aim of engaging in the development of an exosomes-based diagnostic platform for accurate and noninvasive diagnosis of cancer with the help of urine and saliva.

Exosome Diagnostics and Therapeutics Market Report Segmentation Analysis

Key segments that contributed to the exosome diagnostics and therapeutics market analysis derivation are services and applications.

• Based on application, the exosome diagnostics and therapeutics market is segmented into diagnostic and therapeutic applications. In 2023, the diagnostic applications segment held the largest share of the market. Moreover, the therapeutic application segment is expected to grow at the fastest rate during the forecast period.
• By product, the exosome diagnostics and therapeutics market is segmented into instruments, reagents, and software. The instrument segment held the largest share of the market in 2019, and the software segment is estimated to register the highest CAGR in the market during the forecast period.
• The exosome diagnostics and therapeutics market has been segmented by end-user into cancer institutes, hospitals, diagnostic centers, and others. In 2023, the cancer institute segment held the largest share of the market by end user. Moreover, the same segment is expected to grow fastest during the forecast period.

Exosome Diagnostics and Therapeutics Market Share Analysis by Geography

The geographic scope of the exosome diagnostics and therapeutics market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America includes the US, Canada, and Mexico. North America holds the most significant share in the exosome diagnostics and therapeutic market, with the US holding the largest market share, followed by Canada. The US holds the largest share of the exosome diagnostics and therapeutics market, which is attributed to increased demand for the use of exosomes as biomarkers in the diagnosis of cancer, along with the increasing prevalence of cancer, the aging population, and lifestyle changes. Additionally, a robust product pipeline, the presence of major players, and well-developed regulatory policies are projected to drive the North American exosome diagnostic and therapeutic market during the forecast period.

Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of the market in the Asia Pacific region is expected to grow at a faster pace owing to factors such as favorable regulatory scenarios, increasing need for superior treatment solutions, and increasing focus on exosome research and development activities. Additionally, expanding healthcare infrastructure and increasing investments in order to boost research activities are projected to drive the Asia Pacific exosome diagnostic and therapeutic market during the forecast period.

Exosome Diagnostics and Therapeutics Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Exosome Diagnostics and Therapeutic Market News and Recent Developments

The exosome diagnostics and therapeutics market is evaluated by gathering qualitative and quantitative data post post-primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for exosome diagnostics and therapeutic strategies:

• In July 2023, Texas–based Direct Biologics announced promising results from a Phase II trial showing that its exosome, ExoFlo, reduced mortality in long COVID patients with acute respiratory distress syndrome. (Source: Company Press Release)
• In January 2024, EXO Biologics SA, a Belgian biotech company that develops biopharmaceuticals using exosomes to treat rare diseases, launched ExoXpert, a contract development and manufacturing organization (CDMO) specializing in exosomes. (Source: Company Press Release)

Exosome Diagnostics and Therapeutic Market Report Coverage and Deliverables

The “Exosome Diagnostics and Therapeutic Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles